Economic evaluation of second measles containing vaccine (MCV) dose: a systematic review of available evidence

• Main Authors: Samuel Bawa (Author), Abrham Wondimu (Author), Maarten J. Postma (Author), Raymond Hutubessy (Author), Marinus van Hulst (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction The global measles incidence has decreased from 145 to 49 cases per 1 million population from 2000 to 2018, but evaluating the economic benefits of a second measles-containing vaccine (MCV2) is crucial. This study reviewed the evidence and quality of economic evaluation studies to guide...